Classement en actions
#4689
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Prix de l'action
$79.40
Dernière synchronisation: 2026-08-26
Capitalisation boursière
$3.41B
Changement (1 jour)
-3.80%
Changement (1 an)
136.10%
Échange GRAIL Inc. (GRAL)
Le prix GRAL avec la capitalisation boursière de B
Capitalisation boursière de GRAIL Inc.(GRAL)
Capitalisation boursière: $3.41B
En August 2026, GRAIL Inc. a une capitalisation boursière de $3.41B. Cela fait de GRAIL Inc. la 4689th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de GRAIL Inc. du 2024 au 2026
GRAL par rapport au top 5 des plus populaires stocks
| Prix pour GRAL |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.088T
|
+149,210.28%
|
|
|
|
|
$4.629T
|
+135,746.88%
|
|
|
|
|
$4.118T
|
+120,736.31%
|
|
|
|
|
$3.687T
|
+108,091.57%
|
|
|
|
|
$2.800T
|
+82,059.34%
|
